Thursday, April 30, 2020 11:24:32 AM
It's certainly an option!
I'm staying put. I believe that the formal, specified regulatory dates are less important now than the seepage of information from the compassionate use of PLX-PAD in the US and Europe. If results that we have seen from a handful of patients are substantiated by a couple dozen more, the excitement will be impossible (and immoral) to keep hidden. We need therapeutics now, and anything that works will produce headlines quickly.
Furthermore, I do believe that speculation about US regulators trying to suppress Pluristem's work is unfounded. It is inconceivable that people of the caliber of Drs. Fauci and Brix would prevent lifesaving agents from getting to patients.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM